Eli Lilly Expands Zepbound Vial Options and New Savings for Self-Pay Patients
As of February 25, 2025, Eli Lilly and Company has created a self-pay pharmacy component of LillyDirect® where patients with a valid, on-label, electronic prescription from a health care provider of their choice can purchase Zepbound 2.5, 5, 7.5, and 10 mg vials. The press release was made by Patrik Jonsson, executive vice president and president of Lilly Cardiometabolic Health and Lilly USA.
According to the company, this new option could help millions of adults with obesity access the medicine they need, including those not eligible for the Zepbound savings card programme, those without employer coverage and those who need to self-pay outside of insurance. Joe Nadglowski, president and CEO of the Obesity Action Coalition supports this step forward in improving the affordability of obesity treatment.
Lets take a closer look into what this means.
🛌🏻 What does this mean for patients?
Self-pay patients with obesity now have additional Zepbound vial options, including 2.5 mg, 5 mg, 7.5 mg and 10 mg doses through LillyDirect Self Pay Pharmacy Solution. In addition to expanding the doses of Zepbound available, Lilly is taking steps to make Zepbound single dose vials more affordable and offers transparent pricing:
- Lowering the price of the 2.5 mg dose to $349 per month
- Lowering the price of the 5 mg dose to $499 per month
- Launching the new Zepbound Self Pay Journey Program, which reduces the price of the 7.5 mg ($599) and 10 mg ($699) doses to $499 per month at first fill and refills that occur within 45 days of prior delivery
- The single-dose vials are priced at a 50% or greater discount compared to the list price of all other incretin (GLP-1) weight loss drugs, such as Novo Nordisk’s Wegovy (semaglutide)
Distributing the vials via this channel ensures patients and providers can trust they are receiving genuine Lilly medicines.
📝 What is Zepbound?
Zepbound is a weight management drug classed as a glucagon-like peptide-1 (GLP-1) medication, to treat adults with obesity or excess weight and related health issues. Additionally, Zepbound is FDA-approved to treat adults with moderate-to-severe obstructive sleep apnea. Here’s a closer look at Zepbound:
- Contains the active ingredient tirzepatide, a dual-agonist that targets both GLP-1 and GIP receptors (glucose-dependent insulinotropic polypeptide)
- Designed for once-weekly injectable use, it simplifies the regimen for patients
- Not to be combined with other tirzepatide-containing products or GLP-1 receptor agonist medicines
Dosage and administration
- Initial dosage starts at 2.5 mg once per week, with increments to 5 mg after the first month
- Dosage can be increased based on individual response and tolerance, up to a maximum of 15 mg weekly
- The recommended maintenance dosages are 5 mg, 10 mg or 15 mg injected subcutaneously once weekly
- Accompanying lifestyle changes such as a reduced-calorie diet and increased physical activity are recommended for optimal results
Clinical trial outcomes
- In a 17-month clinical study, participants experienced sustained weight loss when combining Zepbound with diet and exercise
- The average weight loss varied, with non-diabetic adults losing up to 20.9% (48 lbs) at the highest dose
- Diabetic patients also saw significant weight loss, shedding an average of 14.7% (33 lbs) at the 15 mg dosage
- As the first FDA-approved combination peptide for obesity, Zepbound’s clinical success has been notable, with some participants losing as much as 21% of their body weight
📝 Conclusion
This news release from Eli Lilly provides self-pay patients with a transparent, out-of-pocket choice, by streamlining the supply chain and providing more accessible options outside of insurance coverage.
Sources
- Lilly launches additional Zepbound vial doses and offers new savings for self-pay patients – Eli Lilly and Company
- Zepbound® (tirzepatide) Injection for Adults with Obesity or OSA
Medical Disclaimer
NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information on this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.
The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.
Related Articles
Can I Trust NowPatient
Our product and services are certified to international healthcare, medical device and data security standards
Medicines Experts
Meet our medical team
We are a broad skilled and passionate group of clinicians with experience of operating in health systems in the United Kingdom & United States. Providing excellent care and advice is at the heart of everything we do. You can read more about our medical team by visiting the medical team page or learn more about how we curate content by visiting our editorial process
WHY WE BUILT NOWPATIENT
We are committed to helping everyone, everywhere live healthier lives
The NowPatient virtual care platform provides you with access to trusted health information, affordable treatments, management of chronic health conditions and continuous monitoring for health risks. NowPatient can be accessed by downloading the App or using your web browser.
Download our app today
Your Questions Answered
For your peace of mind, we can answer your questions quickly
What does NowPatient do?
NowPatient is an online pharmacy & telehealth service that is available in the US and UK. Our service is FREE and packed with useful features that can help you save money on the cost of your medications, access virtual treatments, and provide tools that can help improve your overall health.
Get started today and benefit from medication reminders, Get Treated Privately, NHS online pharmacy, GP appointment booking, Rx savings card, Drug Coupons, US drug savings programs, health conditions information, genetic testing, home test kits, BMI Risks, Type 2 Diabetes Risks, pollen meter, air quality monitor, and lots more!
Our service is operated by experienced medical professionals in the United States and the United Kingdom. You can view the online services that we provide by clicking Features.
UK users can safely and securely buy medicines online that treat a wide range of medical conditions. UK customers can also order NHS prescriptions online with the benefit of free tracked delivery.
US customers, regardless of insurance coverage, can enjoy huge savings on prescription medications using our various drug savings programs including drug coupons, savings card and manufacturer-sponsored patient assistance programs.
Where is NowPatient located?
NowPatient has offices in the United Kingdom and United States.
In the UK, we are located at:
NowPatient
28 Chipstead Valley Road
Coulsdon
Surrey
CR52RA
In the US, we are located at:
NowPatient
8911 North Capital of Texas Highway
Suite 4200 #1263
78759
Austin, TX
How can I contact NowPatient?
To contact NowPatient, please use the contact form available on the Contact Us page.
Alternatively, if you need to speak to us, you can reach us on the following numbers:
UK telephone number – 020 388 51 500
US telephone number – 1-866-967-1977
Who owns NowPatient?
NowPatient is owned and operated by Infohealth Ltd, a licensed online pharmacy with services spanning the UK, US and Rest of the World. Infohealth Ltd is registered in England and Wales under company number 04004930 and our registered office is at Lynwood House, 373 – 375 Station Road, Harrow, England, HA1 2AW.
Our website is www.nowpatient.com. Our App is called “NowPatient” and can be downloaded from the App Store (for Apple devices) or Google Play (for Android devices).
Can you tell me more about your NHS online pharmacy?
NowPatient’s Pharmaceutical services in the UK are provided by Infohealth Limited trading as ‘Infohealth Pharmacy’.
Our dispensing pharmacy is regulated and authorized for internet sales by the General Pharmaceutical Council (GPhC), registration number 1036487. You can view our license credentials on the General Pharmaceutical Council website. Our superintendent pharmacist who is responsible for the safe and effective oversight of medicines supplies is Mr Amish Patel (Registration Number 2042705).
Medicines are not ordinary items of commerce. All medicines or healthcare product sales are made under the supervision of a registered pharmacist who is licensed by the GPhC. At all times, we endeavour to provide a professional and transparent service whose primary goal is to ensure that the best interests of the patient are served.
How do I make a complaint?
From time to time, we accept that our service levels may not be up to your expectations. NowPatient welcomes concerns, compliments and complaints as valuable feedback that will help us learn from your experiences and make improvements. Feedback can be provided via our clear and transparent Complaints Procedures.
Can you tell me more about NowPatient’s prescribing services for treatments offered?
Our prescribing services are regulated by the General Pharmaceutical Council (GPhC). We provide the following regulated activity:
• treatment of disease, disorder, or injury
• transport services, triage, and medical advice are provided remotely
• caring for adults over 65 years old
• caring for adults under 65 years old
NowPatient prescribing services are run by Infohealth Limited. The Clinical Safety Officer and nominated individual is Mr Navin Khosla.
Can you tell me more about NowPatient’s US services?
Our head of US services is Dr. Jamie Winn.
You can lower the cost of your prescription medications using our various savings programs which include drug coupons, savings card and manufacturer-sponsored patient assistance programs.
We do not provide any prescribing services or dispensing services in the United States.
Is NowPatient legit and can I trust information from NowPatient?
Yes. NowPatient provides trustworthy and accessible clinical, health education and prescription services. We are also trusted by the NHS to deliver clinical and NHS repeat prescription dispensing across the whole of England. In the United States, we work with over 65,000 pharmacies to deliver considerable costs savings for our users.
NowPatient is operated by experienced licensed medical professionals in the United Kingdom and United States. Our Medical Team can be found here.
Our service is trusted by thousands of patients worldwide. You can read their reviews on our Trustpilot:
What are NowPatient’s opening hours?
Our office hours are:
UK – Monday-Friday 9am-6pm GMT
US – Monday-Friday 8am-5pm EST
Please note that we are closed at weekends.
In the event of a medical life-threatening emergency please call:
UK – 999
US – 911
In the event of a medical emergency which is not life-threatening please call:
UK – 111